Global Cardiac Troponin Market Price 2024, Forecast To 2033
12 Nov, 2024
The cardiac troponin market has seen rapid expansion, projected to grow from $3.49 billion in 2023 to $3.85 billion in 2024, with a CAGR of 10.3%. Contributing factors include a higher prevalence of cardiovascular diseases, increased awareness and early detection of heart conditions, expanded healthcare infrastructure in emerging markets, an aging population, and the development of high-sensitivity cardiac troponin assays. The cardiac troponin market is projected to grow to $5.73 billion by 2028, at a CAGR of 10.5%. This growth is fueled by the increasing prevalence of cardiovascular conditions, expanding cardiac care units, the rise of home healthcare, personalized medicine, and demand for cost-effective diagnostics. Trends include the use of machine learning in cardiac care, expanding applications of cardiac troponin beyond acute coronary syndrome, and developments in multiplex testing and novel biomarkers.
Major Driver In The Cardiac Troponin Market
The cardiac troponin market is expected to grow due to the rising prevalence of heart-related conditions, including coronary artery disease and heart failure, which are influenced by aging populations and poor lifestyle choices. According to Singapore's 2023 report on ischemic heart diseases, deaths attributed to these conditions rose slightly from 5,290 in 2022 to 5,302 in 2023. This increasing incidence underscores the importance of cardiac troponin as a sensitive biomarker for heart damage, propelling the market forward. With growing healthcare awareness and diagnostics, the cardiac troponin market is projected to expand, reaching $X billion in 2024 and $Y billion by 2028.
Request A Free Sample Of The Cardiac Troponin Market ReportCardiac Troponin Market Competitive Landscape
F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings (Labcorp), Zoetis Inc., bioMérieux SA, Beckman Coulter Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Radiometer Medical ApS, Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Meso Scale Diagnostics LLC., Singulex Inc., Diazyme Laboratories Inc., Response Biomedical Corporation, Eurolyser Diagnostica GmbH, LifeSign LLC
Key Cardiac Troponin Market Trend
In the cardiac troponin market, companies are advancing human serum-based quality control solutions to ensure the accuracy of high-sensitivity troponin testing. In May 2023, Bio-Rad Laboratories launched Cardiac Advance, a multi-analyte quality control designed for troponin testing. This product uses human serum-based controls and is compatible with Siemens and Roche platforms, offering a reliable solution for high-sensitivity cardiac testing in the U.S., Europe, and select Asian markets.
Purchase The Global Cardiac Troponin Market Report Directly And Get A Swift DeliveryGlobal Cardiac Troponin Market Segmentation
The cardiac troponin market covered in this report is segmented –
1) By Type: Troponin I, Troponin T
2) By Location Of Testing: Laboratory Setting, Point Of Care (Poc) Testing
3) By Application: Acute Coronary Syndrome, Myocardial Infraction, Congestive Heart Failure, Other Applications
4) By End User: Hospitals, Diagnostic Centers, Homecare Setting, Other End Users
By Geography:The regions covered in the cardiac troponin market report areAustralia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the cardiac troponin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period.
The Cardiac Troponin Global Market Report 2024 furnishes information about the global cardiac troponin market, encompassing details like market size, projections for growth, segmentation across various sectors and regions, and an overview of competitors, including their revenues, profiles, and market shares. Furthermore, the report pinpoints potential opportunities and strategic directions derived from market trends and the strategies adopted by key competitors. The report also offers an assessment of how the COVID-19 pandemic, the Russia-Ukraine conflict, and increasing inflation have affected both global and regional markets, furnishing valuable strategic insights for businesses.